Mankind Pharma Shares Surge 9% After Strong Q2 Results
Shares extended gains for a second consecutive session on Tuesday after the company’s Q2 FY27 earnings. Brokerages differed on the stock outlook, with Kotak Institutional Equities bullish and Bernstein cautious.
Mankind Pharma shares surged over 9 percent on Tuesday, extending gains for the second consecutive session after the pharmaceutical company's strong Q2 FY27 earnings. Brokerages offered divergent views on the stock, with Kotak Institutional Equities maintaining a bullish outlook, while Bernstein an…